Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally.
Incyte stock last closed at $52.82, up 0.19% from the previous day, and has decreased 28.43% in one year. It has underperformed other stocks in the Biotechnology industry by 0.02 percentage points. Incyte stock is currently +5.07% from its 52-week low of $50.27, and -30.26% from its 52-week high of $75.74.
At the moment, there are 224.53M shares of INCY outstanding. The market capitalization of INCY is $11.86B. In the past 24 hours, 1.83M INCY shares were traded.
How to Buy Incyte Stock
Not sure how to invest in Incyte stock? Here's how.
Figure out where to buy Incyte stock: You need to choose a stock brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Incyte stock.
Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit funds into your brokerage account: Pick your payment method and add your details.
Analyze Incyte stock: The Incyte ticker symbol is INCY. Is Incyte stock a good investment? Should you buy shares of INCY? How do INCY's underlying business fundamentals look? Do top analysts think Incyte is a good buy? Why has INCY's stock price moved recently? (Hint: Our stock market research tools can help you understand if INCY is a good stock to buy).
Execute your INCY purchase: Decide if you will purchase INCY shares at the current market price or use a limit order to buy INCY stock at a particular price.
Monitor your INCY position: Create a watchlist to monitor your new investment in Incyte stock.
Step 1: Figure out where to buy Incyte stock
You will need an online brokerage account in order to access the NASDAQ market and buy INCY shares.
A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Tech to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the world's leading exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've selected the best brokerage, you'll need to fill out some personal details so you can invest in INCY today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Incyte stock
Once you have decided on the best place to buy Incyte stock, it's crucial to evaluate their stock before you invest, so you can wrap your head around the risk as well as the upside.
Incyte quick stats
INCY Price
$52.82
1w %
-3.82%
1y %
-28.43%
5y %
-28.58%
P/E
19.78x
P/B
2.29x
P/S
3.2x
PEG
0.37x
Revenue
$3.70B
Earnings
$597.60M
Fore. Rev. Growth
11.49%
Fore. Earn. Growth
52.77%
Market Cap
$11.86B
Next Earnings
Apr 30, 2024
Next Dividend
N/A
Fundamentals of INCY
WallStreetZen was created to help part-time investors do more in-depth fundamental analysis in less time.
Total INCY debt is lower than 5 years ago, relative to shareholder equity.
There are more short-term assets than short-term liabilities on the INCY balance sheet.
INCY's operating cash flow of $496.49M allows it to safely service it's debt of $32.60M.
INCY profit margin has gone up from 10% to 16.2% in the past year.
INCY has a low debt to equity ratio of 0.31.
INCY earnings of $836.77M is not enough to cover its interest payments.
There are more short-term assets than long-term liabilities on the INCY balance sheet.
Is it a good time to buy INCY stock, according to analysts?
Out of 12 Equities analysts who give forecasts on INCY, the consensus analyst rating on INCY is a Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent INCY Analyst Recommendations
David Lebovitz, a bottom 11% analyst from Citigroup maintains INCY with a strong buy rating and lowers their INCY price target from $82.00 to $81.00, on Feb 14, 2024.
Srikripa Devarakonda, a bottom 14% analyst from Truist Securities maintains INCY with a strong buy rating and lowers their INCY price target from $91.00 to $84.00, on Feb 14, 2024.
Mara Goldstein, a top 29% analyst from Mizuho maintains INCY with a hold rating and lowers their INCY price target from $82.00 to $77.00, on Dec 14, 2023.
Reni Benjamin, a top 10% analyst from JMP Securities reiterates INCY with a buy rating and maintains their INCY price target from $93.00 to $93.00, on Dec 13, 2023.
Andrew Berens, a bottom 2% analyst from Leerink Partners upgrades INCY to a buy rating and announces their INCY price target of $78.00, on Dec 13, 2023.
You can dive deeper into what analysts are projecting on the Incyte stock forecast page.
INCY Technical Indicators
SMA10
54.15
SMA20
55.36
SMA50
57.56
SMA100
58.9
SMA200
59.49
MACD
-1.4
MACD Signal
-1.19
MACD Histogram
-0.2
RSI
26.03
Stochastic %K
4.51
Stochastic %D
2.28
StochRSI %K
2.55
StochRSI %D
0.85
INCY Growth Metrics
Last year, INCY earnings were $597.60M. During the past five year, INCY's earnings have gone up by 38.71% per year. This was faster than the Biotechnology industry average of 15.84%.
Last year, INCY revenue was $3.70B. In the last 5 year, INCY's revenue has increased by 14.45% per year. This was slower than the Biotechnology industry average of 28.98%.
No, Incyte doesn't provide an income stream by paying out dividends.
What others are saying about INCY
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your INCY purchase
There are two main options:
Market order: A market order is an order to buy or sell a security at the best possible price. Market orders are usually the easiest way to buy.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at a specific price, use a limit order.
Click the Open button and eToro will place your order.
If you want more help buying stocks on eToro, watch the how to video below:
As of Apr 18, 2024, it costs $52.82 to buy one share of Incyte stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.189 shares of INCY.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.